Cardio Care Live

CME Speakers

PCSK9

  • Jennifer G. Robinson, MD, MPH

    Jennifer G. Robinson, MD, MPH

    Jennifer G. Robinson, MD, MPH

    Professor, Departments of Epidemiology & Medicine

    Jennifer G. Robinson, MD, MPH, is a professor in the Departments of Epidemiology & Medicine, and is the director of the Prevention Intervention Center in the Department of Epidemiology at the University of Iowa College of Public Health and University of Iowa Hospitals and Clinics in Iowa City. She earned her medical and master of public health degrees from the University of Minnesota School of Medicine and School of Public Health, respectively. Dr Robinson is widely published in her field in such publications as JAMA, American Heart Journal, European Heart Journal, Journal of the American Heart Association, and Circulation, among others.
  • Karol Watson, MD, PhD

    Karol Watson, MD, PhD

    Karol Watson, MD, PhD

    Professor of Medicine/Cardiology

    Karol Watson, MD, PhD, is an attending cardiologist and a professor of medicine/cardiology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). She is the director of the UCLA Women’s Cardiovascular Health Center, the UCLA-Barbra Streisand Women’s Heart Health Program, the co-director of the UCLA Program in Preventive Cardiology, and the director of the UCLA Fellowship Program in Cardiovascular Diseases. She is a principal investigator for several large National Institutes of Health research studies, a fellow of the American College of Cardiology and a member of the American Heart Association. She is a board member of the American Heart Association, Western States Affiliate, and chairperson of the Scientific Advisory Board for Womenheart.
  • Norman E. Lepor, MD

    Norman E. Lepor, MD

    Norman E. Lepor, MD

    Clinical Professor of Medicine

    Norman E. Lepor, MD, FACC, FAHA, FSCAI, earned his MD at Johns Hopkins University School of Medicine in Baltimore, Maryland, and completed his postdoctoral training in cardiology at Cedars-Sinai Medical Center in Los Angeles, California. He is board-certified in internal medicine and cardiovascular diseases by the American Board of Internal Medicine, and is a co-founder of Westside Medical Imaging/Westside Medical Associates of Los Angeles. Dr Lepor is regarded as a national authority in the treatment of hypertension, lipid disorders, heart failure, diabetic heart disease, peripheral vascular disease, and arrhythmias. He has been a primary investigator in several pivotal clinical trials and has written extensively in journals that include JAMA and the American Journal of Cardiology.
  • Alan S. Brown, MD

    Alan S. Brown, MD

    Alan S. Brown, MD

    Clinical Associate Professor

    Alan S. Brown, MD, is the director of the Prevention Center/Lipid Clinic for Midwest Heart Specialists and a clinical associate professor of medicine and cardiology at Loyola Stritch School of Medicine. He is the director of the Division of Cardiology at Advocate Lutheran General Hospital in Park Ridge, Illinois, and is a fellow of the American Heart Association, the National Lipid Association, and the American College of Cardiology. Dr Brown serves on the ACC Task Force for Appropriate Use Criteria, the Board of Directors for the National Lipid Association and the NLA Foundation, is a past president of the Midwest Chapter of the National Lipid Association, and serves on the Board of Directors of the American Society for Preventative Cardiology.
  • Eli M. Roth, MD

    Eli M. Roth, MD

    Eli M. Roth, MD

    President

    Eli M. Roth, MD, is the medical director of Sterling Research Group in Cincinnati, Oho. Board-certified in internal medicine, cardiovascular disease and clinical lipidology, he has more than 24 years of experience in general and interventional cardiology. Dr Roth is currently a professor of clinical medicine and Director of Preventive Cardiology for the Division of Cardiology at the University of Cincinnati College of Medicine. He has more than 12 years of experience in clinical trials and has been principal investigator or sub-investigator on over 500 clinical trials. Dr Roth also has ACRP/APPI certification as a Certified Principal Investigator.

NLA Session Highlights

  • Peter H. Jones, MD, FACP, FNLA

    Peter H. Jones, MD, FACP, FNLA

    Peter H. Jones, MD, FACP, FNLA

    Associate Professor of Medicine

    Peter Howard Jones, MD, FACP, FNLA, is an associate professor in the Department of Medicine, Center for Cardiovascular Disease Prevention at the Baylor College of Medicine in Houston, Texas. He also serves as co-director of the Lipid Metabolism and Atherosclerosis Clinic, and is the medical director for the Weight Management Center at the Houston Methodist Hospital. Dr Jones has served on numerous academic, scientific and community committees, and has published more than 200 clinical abstracts, articles, and chapters in textbooks. He is the chief science officer for the National Lipid Association and an associate editor of the Journal of Clinical Lipidology. Dr Jones received his medical degree from Baylor College of Medicine, where he also completed his internal medicine residency.
  • Christie M. Ballantyne, MD, FNLA

    Christie M. Ballantyne, MD, FNLA

    Christie M. Ballantyne, MD, FNLA

    Professor of Medicine

    Christie Ballantyne, MD, is director for the Center for Cardiovascular Disease Prevention at the Houston Methodist DeBakey Heart & Vascular Center in Texas, as well as vice chair of research for the Department of Medicine, chief of cardiology, and chief of cardiovascular research at Baylor College of Medicine. He is an investigator for the American Heart Association and he receives funding from the National Institutes of Health in basic research of leukocyte-endothelial interactions, translations research in biomarkers and clinical trials. Dr Ballantyne has over 600 publications in the area of atherosclerosis, lipids and inflammation, is an editorial director for www.lipidsonline.org, and is on the editorial board for Circulation. He received is MD from Baylor College of Medicine.

Heart Failure

  • Akshay S. Desai, MD, MPH

    Akshay S. Desai, MD, MPH

    Akshay S. Desai, MD, MPH

    Director, Cardiomyopathy and Heart Failure Program

    Akshay Desai, MD, MPH, is the director of the Cardiomyopathy & Heart Failure Program in the Advanced Heart Disease Section of the Cardiovascular Division, Brigham and Women’s Hospital, and an associate professor of medicine at Harvard Medical School, both in Boston, Massachusetts. He divides his time between treating patients with advanced heart disease and clinical research in cardiovascular clinical trials, with emphasis on pathophysiology, pharmacologic treatment, and ambulatory management of patients with heart failure. He earned his MD from Harvard Medical School, completed an internal medicine internship and residency, as well as cardiovascular medicine and advanced heart failure fellowships, at Brigham and Women’s Hospital. He holds an MPH from the Harvard School of Public Health.
  • James L. Januzzi, Jr., MD, FACC, FESC

    James L. Januzzi, Jr., MD, FACC, FESC

    James L. Januzzi, Jr., MD, FACC, FESC

    Physician, Cardiology Division

    James L. Januzzi, MD, is the Hutter Family Professor of Medicine at Harvard Medical School, a staff cardiologist at Massachusetts General Hospital, and senior cardiometabolic faculty at Baim Institute for Clinical Research in Boston. His research has contributed to the understanding of cardiac biomarker testing, where his studies have set international standards for use in diagnosis, prognosis, and management of patients suffering from acutely decompensated heart failure, chronic heart failure as well as those with acute coronary syndromes. Dr Januzzi has published hundreds of manuscripts, book chapters and review articles, has edited two textbooks on cardiac biomarker testing, and is on the editorial board of numerous scientific journals. He earned his MD from New York Medical College.
  • John D. Goodson, MD

    John D. Goodson, MD

    John D. Goodson, MD

    Physician

    John Goodson, MD, is an associate professor of medicine at Harvard Medical School and a practicing internist at Massachusetts General Hospital (MGH) in Boston, where he is also the founder of the John D. Stoeckle Center for Primary Care Innovation. His focus is on building a strong primary care work force with specific concentration on practice innovation and payment reform. Dr Goodson formed the Cognitive Care Alliance (CCA), which unites professional society representatives from primary care medicine, as well as other specialties, to ensure that patients have access to the cognitive services needed to remain healthy, and that all acute and chronic conditions are thoughtfully and effectively managed. He received his MD from Stanford University School of Medicine in California.
  • Orly Vardeny, PharmD, MS

    Orly Vardeny, PharmD, MS

    Orly Vardeny, PharmD, MS

    Associate Professor of Medicine

Pulmonary Arterial Hypertension

  • Victor F. Tapson, MD, FCCP, FRCP

    Victor F. Tapson, MD, FCCP, FRCP

    Victor F. Tapson, MD, FCCP, FRCP

    Professor of Medicine, Pulmonary Critical Care Medicine

    Victor F. Tapson, MD, FCCP, FRCP, is professor of medicine, director of the Clinical Research for the Women’s Guild Lung Institute and the Venous Thromboembolism and Pulmonary Vascular Disease Research Program, and associate director of the Pulmonary and Critical Care Division at Cedars-Sinai Medical Center in Los Angeles, California. Dr Tapson has devoted his career to patient care, research, and teaching in pulmonary hypertension and pulmonary embolism. He’s served on the steering committees for the World PH Guidelines, started the first PAH journal, Advances in PH, and served as worldwide PI or co-PI for several venous thromboembolism registries. He is currently PI for the OPTALYSE PE, BiO2 IVCF and FLARE clot-extraction studies, and the TAFIa clinical trial in acute PE.

All Speakers

  • Jennifer G. Robinson, MD, MPH

    Jennifer G. Robinson, MD, MPH

    Jennifer G. Robinson, MD, MPH

    Professor, Departments of Epidemiology & Medicine

    Jennifer G. Robinson, MD, MPH, is a professor in the Departments of Epidemiology & Medicine, and is the director of the Prevention Intervention Center in the Department of Epidemiology at the University of Iowa College of Public Health and University of Iowa Hospitals and Clinics in Iowa City. She earned her medical and master of public health degrees from the University of Minnesota School of Medicine and School of Public Health, respectively. Dr Robinson is widely published in her field in such publications as JAMA, American Heart Journal, European Heart Journal, Journal of the American Heart Association, and Circulation, among others.
  • Karol Watson, MD, PhD

    Karol Watson, MD, PhD

    Karol Watson, MD, PhD

    Professor of Medicine/Cardiology

    Karol Watson, MD, PhD, is an attending cardiologist and a professor of medicine/cardiology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). She is the director of the UCLA Women’s Cardiovascular Health Center, the UCLA-Barbra Streisand Women’s Heart Health Program, the co-director of the UCLA Program in Preventive Cardiology, and the director of the UCLA Fellowship Program in Cardiovascular Diseases. She is a principal investigator for several large National Institutes of Health research studies, a fellow of the American College of Cardiology and a member of the American Heart Association. She is a board member of the American Heart Association, Western States Affiliate, and chairperson of the Scientific Advisory Board for Womenheart.
  • Norman E. Lepor, MD

    Norman E. Lepor, MD

    Norman E. Lepor, MD

    Clinical Professor of Medicine

    Norman E. Lepor, MD, FACC, FAHA, FSCAI, earned his MD at Johns Hopkins University School of Medicine in Baltimore, Maryland, and completed his postdoctoral training in cardiology at Cedars-Sinai Medical Center in Los Angeles, California. He is board-certified in internal medicine and cardiovascular diseases by the American Board of Internal Medicine, and is a co-founder of Westside Medical Imaging/Westside Medical Associates of Los Angeles. Dr Lepor is regarded as a national authority in the treatment of hypertension, lipid disorders, heart failure, diabetic heart disease, peripheral vascular disease, and arrhythmias. He has been a primary investigator in several pivotal clinical trials and has written extensively in journals that include JAMA and the American Journal of Cardiology.
  • Alan S. Brown, MD

    Alan S. Brown, MD

    Alan S. Brown, MD

    Clinical Associate Professor

    Alan S. Brown, MD, is the director of the Prevention Center/Lipid Clinic for Midwest Heart Specialists and a clinical associate professor of medicine and cardiology at Loyola Stritch School of Medicine. He is the director of the Division of Cardiology at Advocate Lutheran General Hospital in Park Ridge, Illinois, and is a fellow of the American Heart Association, the National Lipid Association, and the American College of Cardiology. Dr Brown serves on the ACC Task Force for Appropriate Use Criteria, the Board of Directors for the National Lipid Association and the NLA Foundation, is a past president of the Midwest Chapter of the National Lipid Association, and serves on the Board of Directors of the American Society for Preventative Cardiology.
  • Eli M. Roth, MD

    Eli M. Roth, MD

    Eli M. Roth, MD

    President

    Eli M. Roth, MD, is the medical director of Sterling Research Group in Cincinnati, Oho. Board-certified in internal medicine, cardiovascular disease and clinical lipidology, he has more than 24 years of experience in general and interventional cardiology. Dr Roth is currently a professor of clinical medicine and Director of Preventive Cardiology for the Division of Cardiology at the University of Cincinnati College of Medicine. He has more than 12 years of experience in clinical trials and has been principal investigator or sub-investigator on over 500 clinical trials. Dr Roth also has ACRP/APPI certification as a Certified Principal Investigator.
  • Peter H. Jones, MD, FACP, FNLA

    Peter H. Jones, MD, FACP, FNLA

    Peter H. Jones, MD, FACP, FNLA

    Associate Professor of Medicine

    Peter Howard Jones, MD, FACP, FNLA, is an associate professor in the Department of Medicine, Center for Cardiovascular Disease Prevention at the Baylor College of Medicine in Houston, Texas. He also serves as co-director of the Lipid Metabolism and Atherosclerosis Clinic, and is the medical director for the Weight Management Center at the Houston Methodist Hospital. Dr Jones has served on numerous academic, scientific and community committees, and has published more than 200 clinical abstracts, articles, and chapters in textbooks. He is the chief science officer for the National Lipid Association and an associate editor of the Journal of Clinical Lipidology. Dr Jones received his medical degree from Baylor College of Medicine, where he also completed his internal medicine residency.
  • Christie M. Ballantyne, MD, FNLA

    Christie M. Ballantyne, MD, FNLA

    Christie M. Ballantyne, MD, FNLA

    Professor of Medicine

    Christie Ballantyne, MD, is director for the Center for Cardiovascular Disease Prevention at the Houston Methodist DeBakey Heart & Vascular Center in Texas, as well as vice chair of research for the Department of Medicine, chief of cardiology, and chief of cardiovascular research at Baylor College of Medicine. He is an investigator for the American Heart Association and he receives funding from the National Institutes of Health in basic research of leukocyte-endothelial interactions, translations research in biomarkers and clinical trials. Dr Ballantyne has over 600 publications in the area of atherosclerosis, lipids and inflammation, is an editorial director for www.lipidsonline.org, and is on the editorial board for Circulation. He received is MD from Baylor College of Medicine.
  • Akshay S. Desai, MD, MPH

    Akshay S. Desai, MD, MPH

    Akshay S. Desai, MD, MPH

    Director, Cardiomyopathy and Heart Failure Program

    Akshay Desai, MD, MPH, is the director of the Cardiomyopathy & Heart Failure Program in the Advanced Heart Disease Section of the Cardiovascular Division, Brigham and Women’s Hospital, and an associate professor of medicine at Harvard Medical School, both in Boston, Massachusetts. He divides his time between treating patients with advanced heart disease and clinical research in cardiovascular clinical trials, with emphasis on pathophysiology, pharmacologic treatment, and ambulatory management of patients with heart failure. He earned his MD from Harvard Medical School, completed an internal medicine internship and residency, as well as cardiovascular medicine and advanced heart failure fellowships, at Brigham and Women’s Hospital. He holds an MPH from the Harvard School of Public Health.
  • James L. Januzzi, Jr., MD, FACC, FESC

    James L. Januzzi, Jr., MD, FACC, FESC

    James L. Januzzi, Jr., MD, FACC, FESC

    Physician, Cardiology Division

    James L. Januzzi, MD, is the Hutter Family Professor of Medicine at Harvard Medical School, a staff cardiologist at Massachusetts General Hospital, and senior cardiometabolic faculty at Baim Institute for Clinical Research in Boston. His research has contributed to the understanding of cardiac biomarker testing, where his studies have set international standards for use in diagnosis, prognosis, and management of patients suffering from acutely decompensated heart failure, chronic heart failure as well as those with acute coronary syndromes. Dr Januzzi has published hundreds of manuscripts, book chapters and review articles, has edited two textbooks on cardiac biomarker testing, and is on the editorial board of numerous scientific journals. He earned his MD from New York Medical College.
  • John D. Goodson, MD

    John D. Goodson, MD

    John D. Goodson, MD

    Physician

    John Goodson, MD, is an associate professor of medicine at Harvard Medical School and a practicing internist at Massachusetts General Hospital (MGH) in Boston, where he is also the founder of the John D. Stoeckle Center for Primary Care Innovation. His focus is on building a strong primary care work force with specific concentration on practice innovation and payment reform. Dr Goodson formed the Cognitive Care Alliance (CCA), which unites professional society representatives from primary care medicine, as well as other specialties, to ensure that patients have access to the cognitive services needed to remain healthy, and that all acute and chronic conditions are thoughtfully and effectively managed. He received his MD from Stanford University School of Medicine in California.
  • Orly Vardeny, PharmD, MS

    Orly Vardeny, PharmD, MS

    Orly Vardeny, PharmD, MS

    Associate Professor of Medicine

  • Victor F. Tapson, MD, FCCP, FRCP

    Victor F. Tapson, MD, FCCP, FRCP

    Victor F. Tapson, MD, FCCP, FRCP

    Professor of Medicine, Pulmonary Critical Care Medicine

    Victor F. Tapson, MD, FCCP, FRCP, is professor of medicine, director of the Clinical Research for the Women’s Guild Lung Institute and the Venous Thromboembolism and Pulmonary Vascular Disease Research Program, and associate director of the Pulmonary and Critical Care Division at Cedars-Sinai Medical Center in Los Angeles, California. Dr Tapson has devoted his career to patient care, research, and teaching in pulmonary hypertension and pulmonary embolism. He’s served on the steering committees for the World PH Guidelines, started the first PAH journal, Advances in PH, and served as worldwide PI or co-PI for several venous thromboembolism registries. He is currently PI for the OPTALYSE PE, BiO2 IVCF and FLARE clot-extraction studies, and the TAFIa clinical trial in acute PE.